Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
42
KZR Quote, Financials, Valuation and Earnings
Last price:
$6.35
Seasonality move
:
-4.23%
Day range:
$6.24 - $6.36
52-week range:
$3.53 - $6.95
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
0.56x
Volume:
7.5K
Avg. volume:
34.8K
1-year change:
-3.35%
Market cap:
$46.4M
Revenue:
--
EPS (TTM):
-$8.44
Earnings Data
Next earnings date for KZR
Mar 31
2026
Most recent earnings per share
-$1.53
Beat by $0.42
(Nov 12/2025)
Consensus Estimate
-$1.96
(Nov 12/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
KZR Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/31/2026 | Q4 | -- | -- | -- | -$1.31 | -- |
| 11/12/2025 | Q3 | -- | -- | -$1.53 | -$1.96 | $0.42 |
| 08/13/2025 | Q2 | -- | -- | -$1.87 | -$2.32 | $0.45 |
| 05/08/2025 | Q1 | -- | -- | -$2.27 | -$2.65 | $0.38 |
| 03/25/2025 | Q4 | -- | -- | -$2.77 | -$2.76 | -$0.01 |
| 11/12/2024 | Q3 | $666.7K | -- | -$2.78 | -$3.17 | $0.38 |
| 08/13/2024 | Q2 | $500K | -- | -$2.96 | -$3.10 | $0.14 |
| 05/09/2024 | Q1 | $333.3K | -- | -$2.98 | -$3.10 | $0.13 |
| 03/14/2024 | Q4 | -- | -- | -$4.44 | -$3.90 | -$0.54 |
| 11/13/2023 | Q3 | $100K | $7M | -$3.18 | -$3.55 | $0.37 |
| 08/10/2023 | Q2 | -- | -- | -$3.35 | -- | -- |
| 05/11/2023 | Q1 | -- | -- | -$3.07 | -- | -- |
| 03/14/2023 | Q4 | -- | -- | -$2.52 | -- | -- |
| 11/09/2022 | Q3 | -- | -- | -$2.47 | -- | -- |
| 08/11/2022 | Q2 | -- | -- | -$2.52 | -- | -- |
| 05/12/2022 | Q1 | -- | -- | -$2.64 | -- | -- |
| 03/17/2022 | Q4 | -- | -- | -$2.54 | -- | -- |
| 11/09/2021 | Q3 | -- | -- | -$2.78 | -- | -- |
| 08/12/2021 | Q2 | -- | -- | -$2.50 | -- | -- |
| 05/12/2021 | Q1 | -- | -- | -$2.54 | -- | -- |
| 03/11/2021 | Q4 | -- | -- | -$2.18 | -- | -- |
| 11/05/2020 | Q3 | -- | -- | -$2.26 | -- | -- |
| 08/05/2020 | Q2 | -- | -- | -$2.21 | -- | -- |
| 05/07/2020 | Q1 | -- | -- | -$3.05 | -- | -- |
| 03/12/2020 | Q4 | -- | -- | -$5.01 | -- | -- |
| 11/06/2019 | Q3 | -- | -- | -$4.79 | -- | -- |
| 08/07/2019 | Q2 | -- | -- | -$4.57 | -- | -- |
| 05/07/2019 | Q1 | -- | -- | -$4.01 | -- | -- |
| 03/26/2019 | Q4 | -- | -- | -$3.04 | -- | -- |
| 11/08/2018 | Q3 | -- | -- | -$2.99 | -- | -- |
| 08/09/2018 | Q2 | -- | -- | -$33.10 | -- | -- |
| 03/31/2018 | Q1 | -- | -- | -$2.59 | -- | -- |
| 12/31/2017 | Q4 | -- | -- | -$1.77 | -- | -- |
| 09/30/2017 | Q3 | -- | -- | -$1.09 | -- | -- |
| 06/30/2017 | Q2 | -- | -- | -$1.44 | -- | -- |
| 03/31/2017 | Q1 | -- | -- | -$1.18 | -- | -- |
Kezar Life Sciences, Inc. Earnings Questions
-
How Much did Kezar Life Sciences, Inc. Generate in Revenue Last Quarter?
Kezar Life Sciences, Inc. reported -- worth of top line sales in its most recent quarter.
-
Did Kezar Life Sciences, Inc. Beat Earnings Last Quarter?
Kezar Life Sciences, Inc. announced earnings per share of -$1.53 which represents a beat of analyst forecast a -$1.96 per share.
-
Is Kezar Life Sciences, Inc. Profitable?
Kezar Life Sciences, Inc. reported -$227K that represents -$0.03 per share over the last quarter.
-
What is the Analyst Consensus for Kezar Life Sciences, Inc. EPS Next Year?
Kezar Life Sciences, Inc.'s earnings are forecast to decrease from -$11.49 per share to -$6.70 per share next year representing a decrease of -41.63%.
-
When is Kezar Life Sciences, Inc.'s Earnings Date?
Kezar Life Sciences, Inc.'s next earnings date is March 31, 2026.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
68
KOD alert for Dec 25
Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.
Buy
64
ZCSH alert for Dec 25
Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.
